CEO: Nersi Nazari
Based: Campbell, California
Silicon Valley startup VitalConnect made a big splash in the biosigns wearable market earlier this year when it launched its latest version of a wearable vital sign monitor—the VitalPatch. About the size and shape of a Band-Aid, the VitalPatch is a peel-and-stick, single-use device that continuously measures and records single lead ECG, heart rate, heart rate variability, respiratory rate, skin temperature, posture, step count and fall detection with clinical accuracy.
The device sends data via Bluetooth on a mobile device to the VitalConnect platform that allows healthcare providers to access data and receive notifications.
Though the wearables device market has become crowded, VitalConnect made a big impact on investors. In June, the company closed $17.5 million in a term loan from high-profile biotech crossover investor Perceptive Advisors, and upped its Series B round by $7.8 million to $22.1 million.
"Virtual patient monitoring with wearable biosensors is evolving into an important method of care delivery for hospitals and doctors," VitalConnect’s chairman and CEO Dr. Nersi Nazari said at the time of the funding, adding that the financing round only served to confirm “that biosensors are the foundation for improving patient care and the speed of medical response that will lead to better outcomes for future patients.”
The company’s wearable platform is FDA-cleared, CE-marked, Health Canada-approved and Ninsho-certified for use in homes, hospitals and other care facilities.
What makes VitalConnect fierce
The VitalPatch runs on a disposable zinc air battery that powers the device for about three days when using it to monitor ECG—or about four days without it. The measurements are as accurate as VitalConnect’s previous and larger version, the HealthPatch.
What to look for
Given VitalConnect’s extensive background in bioengineering, data analytics, integrated circuit design and manufacturing in the wearable market, the sky may not be the limit for new and creative ways to attach biometric devices to living creatures. According to Berg Insights, by 2020, about 36 million patients will use internet-connected home medical monitoring by 2020. Only about 5 million patients were using them in 2015. — Joseph Keenan, @FierceBiotech